Liaison(s): Alejandro Jatem, Paul deRoulhac
Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. As a member of the Roche group, their work includes the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
The Digital Supply Chain team is evaluating how to accelerate the transformation of the supply chain across the organization through the implementation of emerging technologies in order to connect patients to medicines and innovative solutions faster. These technologies include advanced analytics, internet of things, advanced robotics, edge computing, augmented reality/virtual reality technologies, and blockchain. The implementation of these new digital tools will benefit supply chain capabilities over the years to come.
The Genentech Team Master’s Project team was tasked with researching the supply chain of the future and where the leading supply chain standards will be within five years. To accomplish this, the team identified leaders in supply chain and conducted interviews with key opinion leaders. The KGI team then analyzed the primary research and made recommendations to Genentech to assist with their improvement of their company’s supply chain. The key deliverable included a report documenting these findings and recommendations and a comprehensive presentation showcasing what the KGI team achieved.
2020 FALL CAMPAIGN is happening NOW
Please join us in supporting our students during this critical time with a one-time gift or pledge. Donate now